Detalles de la búsqueda
1.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38721749
2.
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death.
Pharmacol Res
; 197: 106945, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797662
3.
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Am J Hematol
; 98(5): 760-769, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861732
4.
Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study.
J Thromb Thrombolysis
; 56(4): 578-587, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737970
5.
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Ann Hematol
; 101(2): 349-358, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34766217
6.
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.
J Formos Med Assoc
; 121(3): 643-651, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246509
7.
Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study.
Br J Haematol
; 192(1): 110-118, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33131074
8.
Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study.
Oncologist
; 26(11): 974-982, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418220
9.
Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.
Int J Clin Pract
; 75(8): e14258, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884738
10.
Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: a population-based study in Taiwan, 2010-2015.
Immun Ageing
; 17: 17, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536955
11.
Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program.
J Formos Med Assoc
; 119(1 Pt 3): 538-543, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31427121
12.
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study.
Br J Haematol
; 186(1): 72-85, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919947
13.
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
BMC Cancer
; 19(1): 617, 2019 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31234830
14.
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial.
Biol Blood Marrow Transplant
; 24(11): 2310-2315, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026110
15.
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.
Eur J Haematol
; 101(1): 86-94, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29624746
16.
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Biol Blood Marrow Transplant
; 23(8): 1367-1373, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450182
17.
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia.
Blood
; 121(16): 3172-80, 2013 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23449638
18.
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.
BMC Cancer
; 15: 344, 2015 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25934556
19.
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
Ann Hematol
; 94(2): 211-21, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25241285
20.
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.
Blood
; 119(2): 559-68, 2012 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22077061